










































he Assessment of Walking Capacity Using the Walking Index
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ABSTRACT. Kim MO, Burns AS, Ditunno JF Jr, Marino
J. The assessment of walking capacity using the Walking
ndex for Spinal Cord Injury: self-selected versus maximal
evels. Arch Phys Med Rehabil 2007;88:762-7.
Objectives: To assess (1) the frequency and magnitude of
ifferences between self-selected and maximal walking capac-
ty following spinal cord injury (SCI) by using the Walking
ndex for Spinal Cord Injury (WISCI) and (2) how these levels
iffer in efficiency and velocity.
Design: Prospective cohort.
Setting: Academic medical center.
Participants: Fifty people with chronic incomplete SCI.
Interventions: Not applicable.
Main Outcome Measures: Subjects ambulated at the level
sed in the community (self-selected WISCI) and the highest
evel possible (maximal WISCI). Velocity (in m/s), Physiolog-
cal Cost Index (PCI), and Total Heart Beat Index (THBI) were
alculated. Differences were compared using the paired t test
parametric) or Wilcoxon signed-rank test (nonparametric).
Results: For 36 subjects, maximal WISCI was higher than
elf-selected WISCI; 21 subjects showed an increase of 3 levels
r more. Ambulatory velocity was higher for self-selected
ISCI compared with maximal WISCI (.68m/s vs .56m/s,
.001). PCI and THBI at self-selected WISCI were lower
han at maximal WISCI (PCI, 0.99 beats/m vs 1.48 beats/m,
.001; THBI, 3.39 beats/m vs 4.75 beats/m, P.001).
Conclusions: Many people with chronic SCI are capable of
mbulating at multiple levels. For these people, ambulation at
elf-selected WISCI was more efficient as evidenced by greater
elocity and decreased PCI and THBI. The findings have
mplications for assessing walking capacity within the context
f clinical trials.
Key Words: Outcome assessment (health care); Rehabilita-
ion; Spinal cord injuries; Walking.
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alike is to improve walking function following spinal cord
njury (SCI), and several clinical trials are either underway or
ave been recently completed.1,2 Recent advances using animal
odels of SCI have fueled optimism for the therapeutic poten-
ial of future trials.3-6 The success of current and future trials
ill depend on our ability to document meaningful improve-
ent using reliable and valid outcome measures. Recent guide-
ines for clinical trials,7 developed by the International Cam-
aign for Cure and Care of Paralysis, recommended the use of
he Walking Index for Spinal Cord Injury (WISCI)8-10 and
imed walking tests (six-minute walk test [6MWT], ten-meter
alk test [10MWT])11,12 for measuring improvements in walk-
ng function after SCI. Both the WISCI and timed walking tests
ave been validated as measures of functional capacity as-
essed in standardized environments. This distinguishes them
rom disability scales such as the FIM instrument and the
pinal Cord Independence Measure (SCIM), which by defini-
ion assess the function of subjects in different environments.13
Global measures of function often incorporate walking but
o not always specify the adaptations required to enable am-
ulation in the hospital or community. For example, the Mod-
fied Barthel Index (MBI),14 based on the Barthel Index15
eveloped in 1965, evaluates ambulation for 45m (50yd) by
sing a 3-level ordinal scale: dependence, assistance, and in-
ependence. If no physical assistance is needed, the MBI has
he same score (independence) for ambulation with or without
evices.16 The FIM assesses ambulation by using a 7-level
rdinal scale.17,18 With its burden of care focus, the FIM
ssigns higher scores when less physical assistance is required
ut fails to consider bracing. In addition, the FIM does not
ifferentiate the assistive devices (ie, walker, cane) used by
eople who are modified independent. The SCIM, developed
y Catz et al,19 was devised as a global measure that assesses
unction for various aspects of self-care, respiration, bladder
nd bowel management, and mobility. Ambulation is evaluated
or 3 distances by using a 9-level ordinal scale that does
ncorporate the use of devices as well as the use of a wheelchair
t the lower end.
The WISCI is a capacity measure developed solely for the
valuation of walking after SCI.8-10 It is intended for use in
linical trials and consequently describes and rates walking
bility more precisely than the measures outlined earlier. It
onsiders and incorporates the use of physical assistance as
ell as bracing and assistive devices. The hierarchy of levels is
ntended to reflect degree of impairment, with higher scores
ndicating less impairment. Originally described with 19
evels,8 the WISCI was revised and expanded in 2001 to
nclude 21 levels (scored from 0 to 20) (table 1).9
Although the WISCI was developed as a 10-m test, it was
ecognized by its developers that a comprehensive assessment
f walking capacity in clinical trials might require the assess-
ent of distance, speed, and efficiency while walking.8 In
ddition, clinicians are intuitively aware that the requirements
or physical assistance, bracing, and assistive devices are de-
endent on the specific environmental conditions. For instance,






















































763SELF-SELECTED VERSUS MAXIMAL WISCI, Kimay be able to ambulate in the home without the cane. There-
ore, someone may walk at a given WISCI level in the home
ut another (usually lower) WISCI level outdoors. If distance,
peed, and efficiency are to be assessed within the context of
he WISCI, it is important to employ a consistent rationale for
etermining the specific WISCI level at which to measure these
arameters.
The WISCI is currently the only outcome measure devised
pecifically to measure the ambulatory capacity of people after
CI; however, despite its increasing usage, it is still unclear
hether it is better to assess people at their self-selected level
f function or alternatively at the maximum level possible in a
ontrolled environment. We therefore decided to examine the
istribution of self-selected and maximal WISCI levels, how
ften the 2 levels differ, and the magnitude of differences in
eople with chronic SCI. Because future investigators will also
ikely be interested in the speed and efficiency of gait, we were
lso interested in how these parameters differed for the 2
ISCI levels. It was our expectation that speed and efficiency
ould be better at the study subjects’ self-selected level of
unction.
METHODS
Study subjects were recruited from the patient pool of the
egional Spinal Cord Injury Center of the Delaware Valley, a
artnership of Thomas Jefferson University Hospital and Ma-
ee Rehabilitation Hospital, Philadelphia, PA. Candidates were
dentified by using targeted mailings combined with bulletin
Table 1: Scori
Guide by Device
If the subject is unable to stand and/or participate in ass







0 Patient is unable to
1 Parallel bars Brace
2 Parallel bars Brace
3 Parallel bars Brace
4 Parallel bars No b
5 Parallel bars Brace
6 Walker Brace
7 Two crutches Brace
8 Walker No b
9 Walker Brace
10 One cane/crutch Brace
11 Two crutches No b
12 Two crutches Brace
13 Walker No b
14 One cane/crutch No b
15 One cane/crutch Brace
16 Two crutches No b
17 No devices No b
18 No devices Brace
19 One cane/crutch No b
20 No devices No b
EVEL ASSIGNED: __________oard postings and staff involvement in appropriate outpatient olinics. Candidates who expressed an interest in study partici-
ation were then contacted by telephone for additional screen-
ng and scheduling if enrollment criteria were met. Inclusion
riteria included a history of traumatic SCI at least 12 months
reviously, motor incomplete status (American Spinal Injury
ssociation Impairment Scale [AIS] grade C or D), and a
otor level of C4 to L1 inclusive by using the International
tandards for Neurological Classification of Spinal Cord
njury.20 Neurologic status was confirmed by examination be-
ore testing. In addition, subjects had to provide a history of
ndependent lower-extremity weight bearing (standing or am-
ulating), a minimum of once a week, to minimize the risk of
athologic fractures. Subjects were excluded (1) if they were
aking medication that could affect heart rate (ie, ß-blockers or
a-channel blockers) or (2) if they had any history of heart
isease, uncontrolled asthma, or other medical condition that
ould limit their ability to safely ambulate. The study protocol
as approved by the institutional review board and informed
onsent was obtained from all subjects before testing.
Testing was performed by assigned physical therapists
rained in the use of the WISCI. Before testing, the following
ISCI levels were determined: self-selected WISCI and max-
mal WISCI. The self-selected WISCI was defined as the
ISCI level that the subject used to walk in the community or
lternatively the household if community ambulation was not
ossible. The maximal WISCI was defined as the highest level
t which a subject could safely walk 10m, as determined by the
tudy therapists. For WISCI levels requiring assistance of an-
eet of WISCI
walking  level 0
Look to levels:
1, 2, 3, 4, or 5
6, 8, 9, or 13
7, 11, 12, or 16
10, 14, 15, or 19
17, 18, or 20
Assistance Distance
d and/or participate in assisted walking
2 persons 10 meters
2 persons 10 meters
1 person 10 meters
1 person 10 meters
No assistance 10 meters
1 person 10 meters
1 person 10 meters
1 person 10 meters
No assistance 10 meters
1 person 10 meters
1 person 10 meters
No assistance 10 meters
No assistance 10 meters
1 person 10 meters
No assistance 10 meters
No assistance 10 meters
1 person 10 meters
No assistance 10 meters
No assistance 10 meters























racesther person, no more than minimal assistance was allowed.8
















































































764 SELF-SELECTED VERSUS MAXIMAL WISCI, Kim
A
ubjects were asked to ambulate at a comfortable speed for
oth the self-selected WISCI and maximal WISCI levels.
Once self-selected and maximal WISCI levels were defined,
ubjects ambulated back and forth along a marked 10-m length
or a maximum of 10 laps (100m) or alternatively as far as
ossible (distance recorded) (fig 1). Because it was believed
hat fatigue was more likely to affect performance for the
aximal WISCI level, maximal WISCI level testing was per-
ormed first. This also maximized the chance that study sub-
ects would be able to complete the desired 100-m distance for
he maximal WISCI level. Ambulatory capacity was then as-
essed at the less taxing self-selected WISCI level.
Testing was performed on a flat, hard surface. The continu-
us heart rate was recorded by using a Polar heart rate moni-
or.a Polar heart rate data were synchronized to a stopwatch that
ad the capacity to time and save multiple intervals. It was
herefore possible to identify the heart rate data corresponding
o each lap and turn. The entire walking session was timed;
owever, the duration it took the patient to turn at the end of
ach length and the accompanying heartbeats were excluded
rom analysis. Subjects were allowed to rest between maximal
nd self-selected WISCI testing until the heart rate returned to
he basal rate (5 beats/min).
Ambulatory velocity (in m/s) was calculated by dividing the
alking distance by time lapsed. The Physiological Cost Index
PCI) was calculated by using the following equation:
CI (beats ⁄ m) (steady-state heart rate
 resting heart rate) ⁄ ambulatory velocity.21-23
Steady-state heart rate was the average heart rate of the last
lengths, and resting heart rate was the initial heart rate. If
ubjects could not walk the full 100m, the average heart rate of
he last 2 lengths was still used as steady-state heart rate. As a
heck on whether subjects reached steady-state heart rate dur-
ng testing, we compared the calculated steady-state heart rate
ith the average heart rate of the previous length (the 8th
ength for those walking 100m). If steady-state heart rate was
or fewer beats higher than the prior lap, we considered the
ubject to be at steady state. Eighty percent of self-selected
ISCI and 78% of maximal WISCI cases reached steady state
ased on heart rate. Tracings of the continuous heart rate were
isually inspected, and the brief turns between laps did not
ig 1. Diagram for 10-m walking during study. Subject walked 10m,
urned, and walked back in the opposite direction. This was re-
eated for up to 10 lengths (100m). The time that it took to turn at
he end of each length (open arrows) was subtracted from the total
alking time.ppear to impact heart rate.
F
(
rch Phys Med Rehabil Vol 88, June 2007The total heart beat index (THBI) was calculated by using
he equation: THBI (beats/m)  total heart beats during testing/
otal distance traveled.23
Both the PCI and THBI are parameters believed to reflect the
nergy efficiency of gait, and previous studies have been per-
ormed with study subjects ambulating at self-selected
peeds.22-24 The PCI is generally calculated under steady-state
onditions, but THBI is reported to be valid under both steady
nd non–steady-state conditions.23 All 50 study subjects un-
erwent testing; however, additional analysis comparing dif-
erences between the self-selected and the maximal WISCI was
imited to the 36 subjects for which the self-selected and
aximal WISCI levels actually differed. Study parameters
ambulatory velocity, PCI, THBI) were analyzed for significant
ifferences (P.05) using the paired t test or for nonnormally
istributed data, the Wilcoxon signed-rank test.b
RESULTS
Fifty ambulatory subjects with traumatic motor incomplete
CI, of greater than 1 year in duration, were enrolled and
ested. In the United States, approximately 80% of SCIs affect
en.25 Consistent with this, our study subjects were predom-
nantly men (43/50 [86%]) with an average age of 47.413.2
ears (range, 2172y). There were slightly more tetraplegics
28/50 [56%]), and the predominant injury severity was AIS
rade D (45/50 [90%]). The remaining 5 subjects were AIS
rade C.
Both the self-selected and maximal WISCI levels ranged
rom 6 to 20, with a median self-selected WISCI level of 15
nd a median maximal WISCI level of 19. For the self-selected
ISCI, common levels included 19 (n16) followed by 13
n9), 12 (n8), and 15 (n6), respectively (fig 2). For the
aximal WISCI, 24 subjects attained the highest possible
evel, 20. Additional maximal WISCI levels that occurred in 5
r more subjects included 13 (n6), 15 (n5), and 19 (n5).
or 14 subjects, the self-selected and maximal WISCI levels
ere the same; this included 3 subjects whose self-selected
ISCI levels were already 20 and were therefore incapable of
aving a higher maximal WISCI level. For the remaining 36
72%) subjects, the maximal WISCI level was greater than the
elf-selected WISCI level. For 15 subjects, the maximal WISCI
ncreased 1 to 2 levels compared with the self-selected WISCI,
hereas 21 subjects showed an increase of 3 levels or more.ig 2. Distribution of self-selected (self-WISCI) and maximal WISCI

















































765SELF-SELECTED VERSUS MAXIMAL WISCI, Kimhirty-three of the 6 subjects completed the entire 100-m
esting distance at maximal WISCI, whereas 35 of the 36
ubjects walked 100m at self-selected WISCI.
A closer examination of the 36 subjects whose maximal
ISCI exceeded their self-selected WISCI level revealed that
verage ambulatory velocity at self-selected WISCI was sig-
ificantly higher than at maximal WISCI (.68.29m/s; range,
.211.33m/s vs .56.31m/s; range, 0.111.40m/s; paired
test, P.001) (fig 3). Both parameters of energy efficiency,
he PCI and THBI, were significantly lower for self-selected
ISCI compared with maximal WISCI (PCI: .99.57
eats/m; range, 0.222.55 beats/m vs 1.481.24 beats/m;
ange, 0.335.87 beats/m; Wilcoxon signed-rank test,
.001; THBI: 3.391.77 beats/m; range, 1.269.16 beats/m
s 4.753.42 beats/m; range, 1.2516.98 beats/m; Wilcoxon
igned-rank test, P.001) (figs 4, 5). Subjects with chronic SCI
herefore walked faster with less energy expenditure at the
elf-selected WISCI level compared with the maximal WISCI
evel (see figs 3–5).
DISCUSSION
The capacity of people to walk with different combinations
f braces, devices, and physical assistance is an important issue
o consider when planning SCI trials in which the capacity to
ig 3. (A) Differences in ambulatory velocity for self-selected versus
aximal WISCI level and (B) plot of ambulatory velocity by WISCI
evel at self-selected (diamond) and maximal WISCI (square) levels.mbulate will be a measured outcome. Our study confirmed
l
a
hat many clinicians have intuitively recognized, that subjects
ith chronic SCI are capable of ambulating with varying
egrees of bracing, assistive devices, and/or physical assis-
ance. This is likely influenced by the specific environment,
nergy requirements, and other less defined variables. In this
tudy, we assessed walking under 2 conditions: (1) the WISCI
evel used in the community or alternatively the home if the
atient was not capable of community ambulation and (2) the
ighest WISCI level that could be safely attained on a flat-level
urface in our physical therapy department. Of the 47 subjects
ith a self-selected WISCI less than 20, 36 were able to
mbulate safely at a higher WISCI level. For subjects with
igher self-selected WISCI levels, the magnitude of the differ-
nce was, as expected, limited by a ceiling effect. The quality
f ambulation at the maximal WISCI level was adversely
ffected, as reflected by decreased speed and increased energy
xpenditure.
Because inpatient lengths of stay have decreased, more neu-
ologic and functional recovery occurs during the postdis-
harge period. In the United States, the average duration of
npatient rehabilitation after traumatic SCI declined from 115
ays in 1974 to 39 days in 2004.25 Therefore, not all patients
ave the opportunity to continue therapy until recovery has
eached a plateau, and their capacity may be more than real-
ig 4. (A) Differences in PCI for self-selected versus maximal WISCI
evel and (B) plot of PCI by WISCI level at self-selected (diamond)
nd maximal WISCI (square) levels.
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A
zed. For example, a subject who is undergoing a baseline
valuation for a clinical trial may be using a walker because it
s necessary or because that was the patient’s functional capac-
ty at discharge and he/she was never formally progressed. At
tudy follow-up, the subject could progress to using a cane as
result of the study intervention or alternatively because he/she
ealized that he/she was capable of using a cane as part of the
valuation process. This raises the question of whether inves-
igators should use the self-selected mode of walking to track
hanges within the context of a clinical trial or instead test
ubjects at maximal capacity by minimizing the use of assistive
evices, bracing, and physical assistance.
Based on our findings, arguments can be advanced for both
he self-selected and maximal WISCI levels. With regard to the
elf-selected WISCI, it is the level actually used in the com-
unity or household and is therefore more clinically relevant.
econd, the maximal WISCI levels for chronic SCI tend to
luster at the upper end, with a large proportion of people
eaching level 20 (see fig 2). This ceiling effect could limit the
ensitivity of the maximal WISCI for detecting a therapeutic
esponse to an intervention. Alternatively, it might be possible
o test subjects at maximal WISCI and then differentiate sub-
ects at the higher end of the scale using other parameters (ie,
ait efficiency, velocity). Future studies would need to validate
ig 5. (A) Differences in THBI for self-selected versus maximal
ISCI level and (B) plot of THBI by WISCI level at self-selected
diamond) and maximal WISCI (square) levels.uch an approach. If investigators are more interested in ve- b
rch Phys Med Rehabil Vol 88, June 2007ocity or gait efficiency than the actual WISCI level obtained,
t might be preferable to evaluate subjects at maximal WISCI
here a wider range of values was observed.
Assessing patients at maximal capacity requires an under-
tanding of the relation of bracing, assistive devices, and phys-
cal assistance to the underlying motor impairment and walking
bility. As noted earlier, several scales developed to assess
unctional gains during rehabilitation (eg, the MBI, FIM, and
CIM) do not clearly describe the use of braces and devices.
he WISCI was developed specifically to evaluate walking
apacity based on degree of impairment, and as a result, con-
iders these elements. The intent was to maximize sensitivity
or detecting changes in walking capacity, rather than defining
hat constitutes a clinical meaningful change. Morganti et al10
etrospectively compared the WISCI with the MBI, FIM, and
CIM to determine their sensitivities for detecting differences
n walking function after SCI. There were significant correla-
ions between all the scales, with the highest correlation found
etween the WISCI and the SCIM (Spearman .97). The
ensitivity of the WISCI for detecting differences in walking
bilities was greater than that of other scales. This may be
aused in part by the burden of care focus of the MBI and FIM,
ith an accompanying emphasis on physical assistance rather
han devices. The SCIM includes several levels of walking
bility but gives limited consideration to the use of leg braces.
Two timed walking tests, the 6MWT and 10MWT, have
ecently been validated for the measurement of walking capac-
ty after SCI; neither test, however, specifies the required
racing or assistive devices.11,12 Our data indicate that the
ombination of braces and assistive devices is common
WISCI levels 6, 7, 9, 10, 12, 15), and we believe that it is
mportant to differentiate when 1 or both are used. For the
alidation studies of both timed walking tests, subjects were
ested at their self-selected level of walking rather than maxi-
al capacity. It will be important for future studies to deter-
ine which level of walking (self-selected vs maximal) corre-
ates better to the underlying motor impairment associated with
CI.
In this study, we used 2 easily calculated parameters, the PCI
nd THBI, to estimate the efficiency of walking. The direct
easurement of oxygen consumption requires specialized
quipment not generally available in rehabilitation clinics;
easures of gait efficiency, therefore, often use ambulatory
elocity and heart rate to estimate oxygen consumption. The
CI was proposed as an alternative to oxygen consumption
V̇O2) measurements because a linear relation exists between
eart rate and V̇O2 at submaximal loads.
22 However, some
tudies have found that subjects with impairments such as SCI
ay fatigue before reaching steady state or that walking may
ot be a submaximal task.23,26 In our study, 80% of self-
elected WISCI and 78% of maximal WISCI cases reached
teady state based on heart rate. The THBI was developed as an
lternative to the PCI. The THBI has been reported to be very
eproducible at submaximal loads and has a linear relation with
˙ O2 during steady-state and non–steady-state conditions.
23
tudy Limitations
Our study generalizability is limited by the fact that study
ubjects had primarily higher WISCI levels. Twenty subjects
ad self-selected WISCI levels over 18, but only 3 subjects had
elf-selected WISCI levels below 10. This might be a function
f our chosen study population, which consisted of subjects
ith chronic SCI, as well as our inclusion criteria that required
ubjects to weight bear at least once a week. Chronic subjects
t lower WISCI levels are likely to be largely nonambulatory















































767SELF-SELECTED VERSUS MAXIMAL WISCI, Kimunity ambulation. In contrast, subjects who eventually re-
over the ability to ambulate, may transiently progress through
he lower WISCI levels after acute SCI. Although the average
uration from injury was unclear, van Hedel et al12 found that
here was a good correlation between the WISCI level and the
0MWT (Spearman .78) for levels 11 to 20, but a poor
orrelation (.24) for WISCI levels below 11. Future stud-
es are needed to assess and contrast the distribution of WISCI
evels in acute and chronic populations and determine the inter-
nd intrarater reliability of the self-selected and maximal
ISCI.
CONCLUSIONS
Most subjects were able to walk at a higher WISCI level than
heir usual level (ie, with less use of devices and/or physical
ssistance). Gait velocity was lower and energy cost higher at
he higher WISCI levels. This finding has important implica-
ions for assessing changes in ambulation capacity within the
ontext of clinical trials. Study protocols should explicitly state
hether subjects should be tested by using their usual devices
r braces or alternatively by using the least amount of devices
nd assistance possible. Subjects may improve by requiring
ess adaptations (braces, devices, physical assistance) and/or by
mproving speed and efficiency. To avoid confounding by a
hange in devices or assistance, assessment of ambulation
hould document required adaptations and include a measure of
ow the subject walks, such as the WISCI, in addition to
arameters such as velocity and energy cost.
Acknowledgment: We thank Harry Schwartz, MD, of Moss Re-
abilitation Hospital, Philadelphia, PA, for his assistance in identifying
tudy subjects and the performance of the study.
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